beta

AKBA

Akebia Therapeutics Inc.

Akba

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.

Market Cap: 716 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.akebia.com

Shares Outstanding: 47.3 Million

Float: 46.3 Million

Dividend: 0.0 (0.0%)

Beta: 0.800416

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 3.35 Million

Ethical Flags

Animal testing

Longest drawdown: 1856 trading days

From: 2014-06-20 To: 2019-10-18

Lowest Point:

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud